GH1 and pseudotumor cerebri: Each child receiving GH is routinely assessed with complete blood cell count and chemistry profile and monitored for: hypothyroidism, slipped capital femoral epiphysis, hyperglycemia, leukemia, and pseudotumor cerebri.